147 related articles for article (PubMed ID: 23873482)
1. Clinical hypotension with co-prescription of macrolide antibiotics and calcium-channel blockers in haemodialysis patients: a retrospective chart review.
Hiremath S; Ruzicka M; Nagaraju SP; McCormick BB
Drug Saf; 2013 Oct; 36(10):989-93. PubMed ID: 23873482
[TBL] [Abstract][Full Text] [Related]
2. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.
Wright AJ; Gomes T; Mamdani MM; Horn JR; Juurlink DN
CMAJ; 2011 Feb; 183(3):303-7. PubMed ID: 21242274
[TBL] [Abstract][Full Text] [Related]
3. Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics.
Henneman A; Thornby KA
Am J Health Syst Pharm; 2012 Jun; 69(12):1038-43. PubMed ID: 22644980
[TBL] [Abstract][Full Text] [Related]
4. Hypotension induced by the concomitant use of a calcium-channel blocker and clarithromycin.
Takeuchi S; Kotani Y; Tsujimoto T
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28069789
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers + macrolides: elderly patients hospitalised for low blood pressure.
Prescrire Int; 2012 Jul; 21(129):182. PubMed ID: 22852287
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury.
Gandhi S; Fleet JL; Bailey DG; McArthur E; Wald R; Rehman F; Garg AX
JAMA; 2013 Dec; 310(23):2544-53. PubMed ID: 24346990
[TBL] [Abstract][Full Text] [Related]
7. Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis.
Yoshimoto K; Saima S; Nakamura Y; Nakayama M; Kubo H; Kawaguchi Y; Nishitani H; Nakamura Y; Yasui A; Yokoyama K; Kuriyama S; Shirai D; Kugiyama A; Hayano K; Fukui H; Horigome I; Amagasaki Y; Tsubakihara Y; Kamekawa T; Ando R; Tomura S; Okamoto R; Miwa S; Koyama T; Echizen H
Clin Nephrol; 1998 Aug; 50(2):90-3. PubMed ID: 9725779
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and dialysability of isradipine in chronic haemodialysis patients.
Schönholzer K; Marone C
Eur J Clin Pharmacol; 1992; 42(2):231-3. PubMed ID: 1535593
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
[TBL] [Abstract][Full Text] [Related]
10. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning.
Huang J; Buckley NA; Isoardi KZ; Chiew AL; Isbister GK; Cairns R; Brown JA; Chan BS
Clin Toxicol (Phila); 2021 Jun; 59(6):464-471. PubMed ID: 33021397
[TBL] [Abstract][Full Text] [Related]
12. Comparison of losartan with ACE inhibitors and dihydropyridine calcium channel antagonists: a pilot study of prescription-event monitoring in Japan.
Samizo K; Kawabe E; Hinotsu S; Sato T; Kageyama S; Hamada C; Ohashi Y; Kubota K
Drug Saf; 2002; 25(11):811-21. PubMed ID: 12222991
[TBL] [Abstract][Full Text] [Related]
13. A Case of Hypotension and Bradycardia Precipitated by Drug Interaction of Clarithromycin and Calcium-Channel Blocker.
Agrawal V; Chaudhari S; Sy A; Delatre L
J Am Geriatr Soc; 2015 Sep; 63(9):1966-7. PubMed ID: 26389998
[No Abstract] [Full Text] [Related]
14. Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole.
Mishima E; Maruyama K; Nakazawa T; Abe T; Ito S
Intern Med; 2017; 56(13):1687-1690. PubMed ID: 28674358
[TBL] [Abstract][Full Text] [Related]
15. Statin-macrolide interaction risk: a population-based study throughout a general practice database.
Piacentini N; Trifiró G; Tari M; Moretti S; Arcoraci V;
Eur J Clin Pharmacol; 2005 Sep; 61(8):615-20. PubMed ID: 16044339
[TBL] [Abstract][Full Text] [Related]
16. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
Ghamami N; Chiang SH; Dormuth C; Wright JM
Cochrane Database Syst Rev; 2014 Aug; (8):CD010052. PubMed ID: 25173808
[TBL] [Abstract][Full Text] [Related]
17. Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist.
Klotz U
Arzneimittelforschung; 2002; 52(3):155-61. PubMed ID: 11963641
[TBL] [Abstract][Full Text] [Related]
18. Risk of mortality and cardiovascular events following macrolide prescription in chronic rhinosinusitis patients: a cohort study using linked primary care electronic health records.
Williamson E; Denaxas S; Morris S; Clarke CS; Thomas M; Evans H; Direk K; Gonzalez-Izquierdo A; Little P; Lund V; Blackshaw H; Schilder A; Philpott C; Hopkins C; Carpenter J; Programme Team OBOTM
Rhinology; 2019 Aug; 57(4):252-260. PubMed ID: 30928998
[TBL] [Abstract][Full Text] [Related]
19. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
20. Incidence of potential drug interactions in co-prescription of statins and macrolide antibiotics in Croatia during the 14 year period.
Grgurević D; Grgurević J; Vrca VB; Marušić S; Marinović I; Grgurević AB
Pharmazie; 2021 Jun; 76(6):272-278. PubMed ID: 34078522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
